new

SoundHound AI Establishes New Innovation Hub in Bengaluru to Accelerate Global Agentic AI Expansion

SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and…

1 week ago

SANY to Unveil New Machines, Smart Technology, and Service at CONEXPO 2026

LAS VEGAS, Feb. 25, 2026 /PRNewswire/ -- SANY will present its most comprehensive North American portfolio, technology and service at CONEXPO-CON/AGG…

1 week ago

TERREPOWER Hits New Milestone in Sustainable Manufacturing with a 50 MW Solar Lot

DAPHNE, Ala., Feb. 24, 2026 /PRNewswire/ -- TERREPOWER, formerly BBB Industries, a global pure-play aftermarket leader in sustainable manufacturing, today announced…

2 weeks ago

Only 6% of Marketers Have Fully Implemented AI, According to New Supermetrics Report

HELSINKI, Feb. 24, 2026 /PRNewswire/ -- Supermetrics, the Marketing Intelligence Platform trusted by thousands of marketing teams, today released its…

2 weeks ago

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative…

2 weeks ago

ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options

Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate –…

2 weeks ago

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

2 weeks ago

LATHAM & WATKINS ELECTS 22 NEW PARTNERS

Promotions from counsel include skilled practitioners advising clients across transactional, litigation, and regulatory matters.NEW YORK, Feb. 20, 2026 /PRNewswire/ --…

2 weeks ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease…

2 weeks ago

Coca-Cola India Brings Back Rimzim Jeera with a New Campaign that Refuses to be Subtle

NEW DELHI, Feb. 20, 2026 /PRNewswire/ -- India rediscovers its love for local flavours, Coca-Cola is bringing back its cult…

2 weeks ago